Back to Search
CAROL PORTLOCK, MD
MD
Medical Oncology Physician
NPI: 1215028659Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
175872(NY)
Research & Publications (20)
Pegylated interferon plus rituximab in advanced stage, indolent lymphoma: is there CD20 antigen upregulation?
PMID 16923555·Leuk Lymphoma·2006
8-other
Anti-angiogenesis and diffuse large B-cell lymphoma: a new treatment opportunity?
PMID 16840182·Leuk Lymphoma·2006
8-other
Surgery does not improve survival outcomes in people with primary gastric lymphoma.
PMID 15707704·Cancer Treat Rev·2005
8-other
Should radioimmunotherapy be an initial treatment option in advanced-stage follicular lymphoma?
PMID 16075793·Nat Clin Pract Oncol·2005
8-other
The NHL-15 protocol for aggressive non-Hodgkin's lymphomas: a sequential dose-dense, dose-intense regimen of doxorubicin, vincristine and high-dose cyclophosphamide.
PMID 15367410·Ann Oncol·2004
3-trial
Adverse prognostic significance of CD20 positive Reed-Sternberg cells in classical Hodgkin's disease.
PMID 15180859·Br J Haematol·2004
8-other
Nemaline myopathy: a possible late complication of Hodgkin's disease therapy.
PMID 14506646·Hum Pathol·2003
5-case
Rituximab and CHOP for elderly patients with diffuse large B-cell lymphoma.
PMID 12895383·Curr Oncol Rep·2003
8-other
Infectious disease associations in advanced stage, indolent lymphoma (follicular and nonfollicular): developing a lymphoma prevention strategy.
PMID 17965114·Ann Oncol·2008
8-other
Phase 2 study of weekly bortezomib in mantle cell and follicular lymphoma.
PMID 19624539·Br J Haematol·2009
3-trial
The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL).
PMID 19139176·Ann Oncol·2009
8-other
Patients with chemotherapy-refractory mantle cell lymphoma experience high response rates and identical progression-free survivals compared with patients with relapsed disease following treatment with single agent bortezomib: results of a multicentre Phase 2 clinical trial.
PMID 19220284·Br J Haematol·2009
3-trial
Phase II-I-II study of two different doses and schedules of pralatrexate, a high-affinity substrate for the reduced folate carrier, in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies.
PMID 19652067·J Clin Oncol·2009
3-trial
Patients with Epstein Barr virus-positive lymphomas have decreased CD4(+) T-cell responses to the viral nuclear antigen 1.
PMID 18781564·Int J Cancer·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1275 YORK AVE
NEW YORK, NY 10021 - Phone
- (212) 639-2000
Quick Facts
- NPI
- 1215028659
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile